Community Memorial Health adds CEO, Chief of Staff
Mick Zdeblick officially stepped into his new role as the CEO of Community Memorial Health on Jan. 9, replacing Gary Wilde, who retired after helming the position since 2004. Community Memorial Health, which offers a network of services throughout Ventura County, welcomes Zdeblick from Medford, Oregon, where he served as the CEO of Asante Rogue Read More →
Capsida announces multi-year agreement with Eli Lilly subsidiary
Thousand Oaks-based Capsida Therapeutics has entered into a multi-year agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, to develop transformative genetic medicines for serious diseases, Capisda announced Jan. 4. As per the agreement, Capsida will receive $55 million in the form of an upfront payment and a commitment to participate Read More →
Maritime reform bills passed inspired by Conception Boat Fire
The Small Passenger Vessel Liability Fairness Act was signed into law by President Joe Biden on Dec. 23. The measure, championed by Rep. Salud Carbajal, D-Santa Barbara, Sen. Dianne Feinstein and Rep. Julia Brownley, D-Ventura, was crafted in response to the 2019 Conception boat fire off the Central Coast. The law is meant to reform Read More →
Calavo shares down, but company’s optimism remains high for 2023
Shares of Santa Paula-based Calavo Growers faced another steep drop during the trading day Dec. 21, one day after the company’s fourth quarter and full-year earnings announcement. The company limped through the finish line in the fourth quarter, with both revenue and net income falling well below analysts’ expectations. It’s why Calavo’s stock fell as Read More →
New firm wants to play ball at VC Fairgrounds
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Atara receives first drug approval
Thousand Oaks-based Atara Biotherapeutics announced on Dec. 19 that the European Commission has approved its drug, Ebvallo. Ebvallo, also known as tabelecleucel, has been Atara’s main product development in its pipeline since 2015. It is the first time Atara has received approval for one of its treatments. The drug is a monotherapy for the treatment Read More →
